Ethylenediamine

Ethylenediamine

SCHEMBL2160624

NCCN.NCCN.NCCN.O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Ethylenediamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 1/20 0.44
TSHR P16473 4/20 0.40
CA12 O43570 4/20 0.40
CA6 P23280 4/20 0.40
CA7 P43166 4/20 0.40
CA9 Q16790 4/20 0.40
CA14 Q9ULX7 4/20 0.40
CA5B Q9Y2D0 4/20 0.40
ALDH1A1 P00352 4/20 0.40
LMNA P02545 4/20 0.40
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
CA3 P07451 3/20 0.40
CA4 P22748 3/20 0.40
CA5A P35218 3/20 0.40
BLM P54132 2/20 0.40
DNM1 Q05193 1/20 0.40
CYP3A4 P08684 1/20 0.40
LOX P28300 1/20 0.39
LOXL3 P58215 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylenediamine SCHEMBL10872598 1.00 NFKB1 (0.44) NFKB1TSHRCA12CA6CA7
Ethylenediamine SCHEMBL1092094 1.00
Ethylenediamine SCHEMBL29199091 1.00
Ethylenediamine SCHEMBL5083587 1.00
Ethylenediamine SCHEMBL6764924 1.00 NFKB1 (0.44) NFKB1TSHRCA12CA6CA7
Ethylenediamine SCHEMBL2835100 1.00 NFKB1 (0.44) NFKB1TSHRCA12CA6CA7
Ethylenediamine SCHEMBL2473294 1.00
Ethylenediamine SCHEMBL30457614 1.00 NFKB1 (0.44) NFKB1TSHRCA12CA6CA7
Ethylenediamine SCHEMBL8366397 0.93
Ethylenediamine SCHEMBL9074178 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1141441-B1 METHOD FOR FORMING A METAL ALLOY COATING OF THE TYPE MCrAlY ONERA (OFF NAT AEROSPATIALE) (FR) 2003-02-19 EP claimed
EP-2354165-A1 Aeropolysaccharides, composites and preparation thereof Technion Research and Development Foundation, Ltd. (IL) 2011-08-10 EP disclosed
US-20110180751-A1 AEROPOLYSACCHARIDES, COMPOSITES AND PREPARATION THEREOF TECHNION R&D FOUNDATION LTD. (IL) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110180751-A1 AEROPOLYSACCHARIDES, COMPOSITES AND PREPARATION THEREOF ALG1, CHIT1, ARSA NFKB1 4031/4885TSHR 4726/4885CA12 635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.